Anette Lykke Petri
Overview
Explore the profile of Anette Lykke Petri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Azawi N, Christensen T, Petri A, Kehlet H
Dan Med J
. 2012 Jun;
59(6):A4446.
PMID: 22677244
Introduction: Implementation of the principles of a fast-track surgical programme resulted in a decrease in the length of hospital stay after open nephrectomies. The aim of this study was to...
2.
Petri A, Simonsen A, Hogdall E, Christensen I, Kjaer S, Yip C, et al.
Proteomics Clin Appl
. 2010 Dec;
4(3):304-14.
PMID: 21137051
Purpose: The purposes of this study were to confirm previously found candidate epithelial ovarian cancer biomarkers in urine and to compare a paired serum biomarker panel and a urine biomarker...
3.
Hogdall E, Fung E, Christensen I, Yip C, Nedergaard L, Engelholm S, et al.
Proteomics Clin Appl
. 2010 Dec;
4(12):940-52.
PMID: 21137034
Purpose: To determine if the level of apolipoprotein A1, hepcidin, transferrin, inter-α trypsin IV internal fragment, transthyretin (TT), connective-tissue activating protein 3 (CTAP3), serum amyloid A1, β-2 microglobulin (B2M) might...
4.
Petri A, Hogdall C, Christensen I, Simonsen A, Tjampens D, Hellmann M, et al.
Proteomics Clin Appl
. 2010 Dec;
2(9):1184-93.
PMID: 21136916
Because of its non-invasive sample collection method, human urine is an attractive biological material both for discovering biomarkers and for use in future screening trials for different diseases. Before urine...
5.
Begum F, Hogdall E, Christensen I, Christensen L, Kjaer S, Blaakaer J, et al.
Gynecol Oncol
. 2010 Mar;
117(3):446-50.
PMID: 20304468
Objective: The association between tetranectin (TN) and selected lifestyle factors (smoking and alcohol) and the postoperative complication rate for ovarian cancer (OC) patients undergoing primary cytoreductive surgery has not yet...
6.
Utzon J, Petri A, Christophersen S
Ugeskr Laeger
. 2009 Sep;
171(38):2723-7.
PMID: 19758494
There is little agreement on the philosophy of measuring clinical quality in health care. How data should be analyzed and transformed to healthcare information is an ongoing discussion. To accept...
7.
Petri A, Kjaer S, Christensen I, Blaakaer J, Hogdall E, Jeppesen U, et al.
Acta Obstet Gynecol Scand
. 2009 Mar;
88(5):536-42.
PMID: 19308749
Objective: To validate the data on epithelial ovarian cancer, fallopian tube cancer and borderline ovarian tumors registered in the nationwide Danish Gynecological Cancer Database (DGCD) in 2005 and 2006. The...
8.
Petri A, Hogdall C, Lidegaard O
Ugeskr Laeger
. 2009 Feb;
171(6):408-11.
PMID: 19208328
The purpose of this status article was to summarise the registration of ovarian cancer in Denmark up to 2007. In Denmark ovarian cancer is registered in four different registers/databases: The...
9.
Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology
Petri A, Simonsen A, Yip T, Hogdall E, Fung E, Lundvall L, et al.
Acta Obstet Gynecol Scand
. 2008 Nov;
88(1):18-26.
PMID: 19023702
Objective: To examine whether urine can be used to measure specific ovarian cancer proteomic profiles and whether one peak alone or in combination with other peaks or CA125 has the...
10.
Tonnesen H, Roswall N, Odgaard M, Pedersen K, Larsen K, Mathiassen B, et al.
Ugeskr Laeger
. 2008 May;
170(20):1747-52.
PMID: 18489891
Introduction: Lifestyle factors are important for clinical outcome. Systematic and early identification of these factors is important in order to offer relevant lifestyle intervention programmes. The objective was to evaluate...